Mohammadzadeh Niloofar, Rezayi Sorayya, Tanhapour Mozhgan, Saeedi Soheila
Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Clinical Research Development Unit of Farshchian Heart Center, Hamadan University of Medical Sciences, Hamadan, Iran; Health Information Management and Medical Informatics Department, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Int J Med Inform. 2021 Dec 11;158:104663. doi: 10.1016/j.ijmedinf.2021.104663.
The prevalence and mortality of cardiovascular diseases are high worldwide. Telecardiology can be used to diagnose and treat these diseases. This paper aimed to review the effectiveness (positive and negative) of implemented telecardiology services in terms of clinical, economic, and patient-reported aspects.
A comprehensive search was conducted in Medline (through PubMed), Scopus, ISI web of science, and IEEE Xplore databases from inception to April 7, 2021. the studies that examined the effectiveness of telecardiology interventions were included.
Fifty studies were included in this systematic review. Most investigations (22%) were conducted in the US. In 22% of studies, telecardiology intervention was used for patients with heart failure. Telecardiology has been used in most studies for tele-monitoring (n = 21, 42%) and tele-consultation (n = 17, 34%) and in 29 studies (58%), was applied for ECG transmission. The highest rate of effects reported by studies was clinical. Thirty-five studies (70%) reported the clinical effects; twenty-one studies reported the positive effects for the economic category, and fifteen studies reported the positive effect for patient-reported class. The most positive clinical effects of telecardiology were early diagnosis, early treatment, and mortality reduction. The most positive effect of the economic class was the reduction of health care costs. The most effects of the patient-reported category were improving the patient's quality of life and patient satisfaction.
Telecardiology can help early diagnosis and treatment of cardiovascular diseases. It also has great potential in reducing health care costs and increasing quality of life and patient satisfaction.
心血管疾病在全球范围内的患病率和死亡率都很高。远程心脏病学可用于诊断和治疗这些疾病。本文旨在从临床、经济和患者报告等方面综述已实施的远程心脏病学服务的有效性（积极和消极方面）。
从创刊至2021年4月7日，在Medline（通过PubMed）、Scopus、科学引文索引网络版和IEEE Xplore数据库中进行了全面检索。纳入了检验远程心脏病学干预有效性的研究。
本系统评价纳入了50项研究。大多数调查（22%）在美国进行。在22%的研究中，远程心脏病学干预用于心力衰竭患者。在大多数研究中，远程心脏病学用于远程监测（n = 21，42%）和远程会诊（n = 17，34%），在29项研究（58%）中用于心电图传输。研究报告的最高效果类别是临床方面。35项研究（70%）报告了临床效果；21项研究报告了经济方面的积极效果，15项研究报告了患者报告类别的积极效果。远程心脏病学最积极的临床效果是早期诊断、早期治疗和降低死亡率。经济类最积极的效果是降低医疗保健成本。患者报告类别的最大效果是提高患者的生活质量和患者满意度。
远程心脏病学有助于心血管疾病的早期诊断和治疗。它在降低医疗保健成本、提高生活质量和患者满意度方面也具有巨大潜力。
